BioMarin Pharmaceutical Depreciation & Amortization 2011-2025 | BMRN

Annual Depreciation & Amortization BioMarin Pharmaceutical

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
96.4 M	104 M	102 M	108 M	105 M	105 M	95.7 M	87.9 M	96.9 M	47.2 M	45.9 M	36 M	45.3 M	36.1 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
108 M	36 M	79.4 M

Quarterly Depreciation & Amortization BioMarin Pharmaceutical

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
10.6 M	22.1 M	-	10.9 M	11.5 M	27.4 M	-	9.9 M	9.4 M	26.4 M	-	8.7 M	9.5 M	27.3 M	-	82.1 M	11.8 M	28 M	-	77.8 M	51.2 M	26 M	-	79.5 M	48.8 M	22.4 M	-	71 M	44.6 M	23.6 M	-	59.2 M	38.5 M	19.4 M	-	76.8 M	47.4 M	18.7 M	-	34.3 M	22.3 M	10.8 M	-	39.9 M	25.7 M	12 M	-	37.5 M	24.2 M	11.3 M	-	33.4 M	21.8 M	10.6 M	-	26.5 M	17.1 M	8.58 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
82.1 M	8.58 M	30.4 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Aclaris Therapeutics ACRS	807 K	$ 3.01	-0.66 %	$ 233 M	USA
Aptevo Therapeutics APVO	352 K	$ 0.55	-9.41 %	$ 152 K	USA
Autolus Therapeutics plc AUTL	7.55 M	$ 1.88	12.57 %	$ 480 M	Britain
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aptorum Group Limited APM	1.13 M	$ 1.14	-0.35 %	$ 6.22 M	China
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
BioVie BIVI	229 K	$ 1.19	-2.07 %	$ 1.76 M	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Bellicum Pharmaceuticals BLCM	11 K	-	-9.72 %	$ 5.89 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Can-Fite BioPharma Ltd. CANF	14 K	$ 0.18	-15.31 %	$ 392 M	Israel
Adaptimmune Therapeutics plc ADAP	9.45 M	-	-15.15 %	$ 60.3 M	Britain
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Catalyst Biosciences CBIO	1.07 M	$ 12.25	-0.85 %	$ 806 M	USA
Amphastar Pharmaceuticals AMPH	28.2 M	$ 26.88	-0.88 %	$ 1.3 B	USA
BeiGene, Ltd. BGNE	172 M	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	300 K	-	-10.95 %	$ 876 K	USA
Certara CERT	1.99 M	$ 8.84	-0.56 %	$ 1.42 B	USA
Anika Therapeutics ANIK	6.43 M	$ 9.51	-0.42 %	$ 139 M	USA
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Axon Enterprise AXON	48.4 M	$ 581.18	-0.45 %	$ 44 B	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	5.38 M	$ 2.5	2.04 %	$ 15.7 M	USA
ChromaDex Corporation CDXC	663 K	-	-0.88 %	$ 598 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	41 K	-	-5.38 %	$ 6.06 M	USA
Celldex Therapeutics CLDX	3.18 M	$ 26.01	-1.48 %	$ 1.67 M	USA